CSRxP Releases Comments on Drug Price Blueprint
Jul 13, 2018
The Department of Health and Human Services is taking a good first step in the… Read More
© 2025 CSRXP- All Rights Reserved
Updates
Statement on Celgene’s Revlimid Price Hike
Jul 10, 2018
CSRxP spokesman Will Holley released the following statement in response to… Read More
CSRxP Applauds Secretary Azar’s Focus on List Prices
Jun 26, 2018
CSRxP spokesman Will Holley released the following statement in response to… Read More
CSRxP Testimony for the Record: Senate Finance Committee Hearing on Rx Prices
Jun 25, 2018
The Campaign for Sustainable Rx Pricing today released testimony for the… Read More
CSRxP Applauds Senate Judiciary Committee for Vote on CREATES Act
Jun 14, 2018
“We applaud the members of the Senate Judiciary Committee for voting the… Read More
CSRxP Statement on Secretary Azar’s Testimony in Front of Senate HELP Committee
Jun 12, 2018
“When the manufacturer-set price of a drug starts out high… Read More
46 Signatories Applaud Grassley & Feinstein for CREATES Act Markup
Jun 7, 2018
46 organizations today applauded Chairman Chuck Grassley and Ranking Member… Read More
CSRxP Statement on HHS OIG Part D Spending Report
Jun 4, 2018
Today, the Office of the Inspector General at the Department of Health and… Read More
CSRxP Applauds FDA’s Focus on REMS Abuses
May 31, 2018
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP Applauds FDA’s Transparency on Brand “Gaming” Tactics
May 17, 2018
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP on President Trump’s Remarks on Drug Prices
May 11, 2018
The Campaign for Sustainable Rx Pricing released the following statement… Read More
CSRxP Launches TV & Digital Ad Campaign Urging Congress to Pass the CREATES Act
Mar 8, 2018
March 8, 2018 Contact: [email protected] ( 202) 286-4682 The Campaign for… Read More